News
The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.
When former President Joe Biden revealed he had been diagnosed with prostate cancer earlier this year, it reignited a ...
1d
SurvivorNet on MSNAdvanced Prostate Cancer Update: Adding PARP Inhibitor To Standard Of Care Can Notably Improve OutcomesPatients with metastatic castration-sensitive prostate cancer (mCSPC), who have specific genetic mutations, were found to ...
As with the drug's 2023 approval in castration-resistant tumors, it's not clear if it works comparably in all homologous ...
Jay Harris, who has anchored for SportsCenter for over 10 years has shared he has been diagnosed with prostate cancer and ...
Adding niraparib to abiraterone acetate and prednisone may help slow cancer growth for patients with metastatic ...
BY DR. AMANI JAMBHEKARCHRISTUS St. Vincent Specialists ClinicLos Alamos My name is Amani Jambhekar and I’m a breast cancer and melanoma surgeon in Santa Fe, NM. I’m also certified in Cancer ...
ALTON Other than skin cancer, prostate cancer is the most common cancer in men in the United States.According to the American ...
2d
Tribune Content Agency on MSNLet’s not call it cancerRoughly one in six men will be diagnosed with prostate cancer at some point in their lives, but these cancers usually aren’t ...
Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple ...
According to J&J, Akeega is the first PARP inhibitor combination that’s proven effective treating earlier-stage prostate ...
With June being Men’s Health Month, did you know that approximately 313,780 men will be diagnosed with prostate cancer this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results